Search

everythinglearnresearchcommunity

for

Search:↓

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Minoxidil can cause a skin reaction called ALEP.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Understanding how acne develops in different diseases could lead to new treatments.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

New understanding and treatments for hair loss are improving, but more research is needed.

Lentiginous melanoma is most common on the face, especially the nose, cheek, and pre-auricular areas, with men more likely to have it on the scalp, ears, upper back, and trapezius, and women on the cheek and anterior arm. Sun damage is a key factor in its formation.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.